ResourceLife Sciences
IRDye<sup>®</sup> 800CW 2-DG Optical Probe is Described.
14 Jun 2011This application note from LI-COR outlines the use of IRDye® 800CW 2-DG, a fluorescent optical imaging agent that has been shown to be reactive with implanted tumors derived from a number of cell lines and should find use in research pertaining to tumor biology, its metastases, and diabetes. In this investigation, two examples in which IRDye 800CW 2-DG was used to detect subcutaneous A431 tumors are shown.
Related products
Request Quote for All Products
IRDye 800CW Infrared Dyes
LICORbioImaging probes conjugated to IRDye 800CW and IRDye 700DX have propelled more than 20 Phase I and Phase II clinical trials worldwide.
Links
Tags
Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.In Vivo Imaging Systems<i>In vivo</i> imaging systems, including pre-clinical imaging systems and medical imaging systems are used to non-invasively visualize and capture images of live animals and plants. Monitor the natural processes or diseases of your subjects using small-animal pre-clinical imaging systems, including single photon positron emission tomography (SPECT), positron emission tomography (PET), computed tomography (micro-CT), magnetic resonance imaging (MRI), X-ray radiography, ultrasound, fluorescence and bioluminescence imagers. Multimodal systems and software solutions are also available for correlative analysis of organ, tissue, cell, or molecular-level processes. Find the best in vivo imaging products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.